Integra LifeSciences Holdings Gross Margin 2012-2026 | IART
Current and historical gross margin for Integra LifeSciences Holdings (IART) over the last 10 years. The current gross profit margin for Integra LifeSciences Holdings as of March 31, 2026 is %.
| Integra LifeSciences Holdings Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2026-03-31 | $1.65B | $0.85B | 51.91% |
| 2025-12-31 | $1.64B | $0.83B | 50.79% |
| 2025-09-30 | $1.64B | $0.86B | 52.25% |
| 2025-06-30 | $1.62B | $0.85B | 52.50% |
| 2025-03-31 | $1.63B | $0.87B | 53.48% |
| 2024-12-31 | $1.61B | $0.88B | 54.75% |
| 2024-09-30 | $1.57B | $0.86B | 54.89% |
| 2024-06-30 | $1.57B | $0.88B | 56.00% |
| 2024-03-31 | $1.53B | $0.86B | 56.12% |
| 2023-12-31 | $1.54B | $0.88B | 57.37% |
| 2023-09-30 | $1.54B | $0.91B | 58.88% |
| 2023-06-30 | $1.55B | $0.93B | 60.00% |
| 2023-03-31 | $1.56B | $0.97B | 62.04% |
| 2022-12-31 | $1.56B | $0.97B | 62.26% |
| 2022-09-30 | $1.57B | $0.97B | 61.88% |
| 2022-06-30 | $1.57B | $0.97B | 62.12% |
| 2022-03-31 | $1.56B | $0.96B | 61.79% |
| 2021-12-31 | $1.54B | $0.94B | 61.18% |
| 2021-09-30 | $1.53B | $0.94B | 61.40% |
| 2021-06-30 | $1.51B | $0.93B | 61.63% |
| 2021-03-31 | $1.38B | $0.84B | 61.25% |
| 2020-12-31 | $1.37B | $0.85B | 62.03% |
| 2020-09-30 | $1.38B | $0.86B | 62.05% |
| 2020-06-30 | $1.39B | $0.86B | 61.72% |
| 2020-03-31 | $1.51B | $0.94B | 62.37% |
| 2019-12-31 | $1.52B | $0.95B | 62.78% |
| 2019-09-30 | $1.51B | $0.94B | 62.68% |
| 2019-06-30 | $1.49B | $0.93B | 62.36% |
| 2019-03-31 | $1.48B | $0.92B | 62.37% |
| 2018-12-31 | $1.47B | $0.90B | 61.28% |
| 2018-09-30 | $1.46B | $0.89B | 60.70% |
| 2018-06-30 | $1.37B | $0.84B | 61.20% |
| 2018-03-31 | $1.29B | $0.79B | 61.62% |
| 2017-12-31 | $1.19B | $0.75B | 63.25% |
| 2017-09-30 | $1.08B | $0.70B | 65.24% |
| 2017-06-30 | $1.05B | $0.69B | 65.52% |
| 2017-03-31 | $1.01B | $0.66B | 65.38% |
| 2016-12-31 | $0.99B | $0.64B | 64.82% |
| 2016-09-30 | $0.98B | $0.62B | 63.87% |
| 2016-06-30 | $0.95B | $0.60B | 63.27% |
| 2016-03-31 | $0.92B | $0.58B | 63.25% |
| 2015-12-31 | $0.88B | $0.56B | 62.85% |
| 2015-09-30 | $0.80B | $0.50B | 62.52% |
| 2015-06-30 | $0.77B | $0.48B | 62.71% |
| 2015-03-31 | $0.79B | $0.49B | 62.17% |
| 2014-12-31 | $0.80B | $0.49B | 61.98% |
| 2014-09-30 | $0.73B | $0.45B | 61.52% |
| 2014-06-30 | $0.74B | $0.45B | 61.22% |
| 2014-03-31 | $0.72B | $0.43B | 60.56% |
| 2013-12-31 | $0.70B | $0.42B | 59.83% |
| 2013-09-30 | $0.83B | $0.51B | 60.84% |
| 2013-06-30 | $0.83B | $0.51B | 61.06% |
| 2013-03-31 | $0.83B | $0.51B | 61.73% |
| 2012-12-31 | $0.83B | $0.52B | 62.41% |
| 2012-09-30 | $0.82B | $0.51B | 61.71% |
| 2012-06-30 | $0.81B | $0.50B | 61.45% |
| 2012-03-31 | $0.80B | $0.49B | 61.26% |
| 2011-12-31 | $0.78B | $0.48B | 61.67% |
| 2011-09-30 | $0.77B | $0.48B | 62.73% |
| 2011-06-30 | $0.76B | $0.48B | 63.05% |
| 2011-03-31 | $0.74B | $0.47B | 63.43% |
| 2010-12-31 | $0.73B | $0.46B | 63.17% |
| 2010-09-30 | $0.72B | $0.46B | 63.62% |
| 2010-06-30 | $0.71B | $0.45B | 63.84% |
| 2010-03-31 | $0.70B | $0.44B | 63.88% |
| 2009-12-31 | $0.68B | $0.44B | 64.13% |
| 2009-09-30 | $0.67B | $0.42B | 63.00% |
| 2009-06-30 | $0.67B | $0.42B | 62.57% |
| 2009-03-31 | $0.66B | $0.41B | 62.37% |
| 2008-12-31 | $0.65B | $0.40B | 61.47% |
| 2008-09-30 | $0.64B | $0.39B | 61.29% |
| 2008-06-30 | $0.61B | $0.37B | 61.39% |
| 2008-03-31 | $0.58B | $0.36B | 60.79% |
| 2007-12-31 | $0.55B | $0.34B | 60.80% |
| 2007-09-30 | $0.52B | $0.31B | 60.62% |
| 2007-06-30 | $0.50B | $0.30B | 59.80% |
| 2007-03-31 | $0.47B | $0.28B | 59.35% |
| 2006-12-31 | $0.42B | $0.25B | 59.90% |
| 2006-09-30 | $0.37B | $0.22B | 60.22% |
| 2006-06-30 | $0.32B | $0.20B | 61.13% |
| 2006-03-31 | $0.29B | $0.18B | 61.59% |
| 2005-12-31 | $0.28B | $0.17B | 61.15% |
| 2005-09-30 | $0.27B | $0.16B | 61.05% |
| 2005-06-30 | $0.26B | $0.16B | 61.09% |
| 2005-03-31 | $0.24B | $0.15B | 61.73% |
| 2004-12-31 | $0.23B | $0.14B | 61.57% |
| 2004-09-30 | $0.23B | $0.14B | 62.83% |
| 2004-06-30 | $0.21B | $0.13B | 62.15% |
| 2004-03-31 | $0.20B | $0.12B | 61.69% |
| 2003-12-31 | $0.19B | $0.12B | 61.83% |
| 2003-09-30 | $0.16B | $0.10B | 60.49% |
| 2003-06-30 | $0.15B | $0.09B | 60.69% |
| 2003-03-31 | $0.13B | $0.08B | 61.72% |
| 2002-12-31 | $0.12B | $0.07B | 61.54% |
| 2002-09-30 | $0.11B | $0.07B | 61.68% |
| 2002-06-30 | $0.10B | $0.06B | 62.38% |
| 2002-03-31 | $0.10B | $0.06B | 62.24% |
| 2001-12-31 | $0.09B | $0.06B | 61.70% |
| 2001-09-30 | $0.09B | $0.06B | 61.80% |
| 2001-06-30 | $0.09B | $0.05B | 61.18% |
| 2001-03-31 | $0.08B | $0.05B | 59.49% |
| 2000-12-31 | $0.07B | $0.04B | 58.33% |
| 2000-09-30 | $0.07B | $0.04B | 56.92% |
| 2000-06-30 | $0.06B | $0.03B | 54.39% |
| 2000-03-31 | $0.05B | $0.03B | 49.06% |
| 1999-12-31 | $0.04B | $0.02B | 46.51% |
| 1999-09-30 | $0.04B | $0.02B | 42.86% |
| 1999-06-30 | $0.03B | $0.01B | 44.44% |
| 1999-03-31 | $0.02B | $0.01B | 50.00% |
| 1998-12-31 | $0.02B | $0.01B | 55.56% |
| 1998-09-30 | $0.02B | $0.01B | 68.75% |
| 1998-06-30 | $0.02B | $0.01B | 62.50% |
| 1998-03-31 | $0.02B | $0.01B | 62.50% |
| 1997-12-31 | $0.01B | $0.01B | 64.29% |
| 1997-09-30 | $0.02B | $0.01B | 46.67% |
| 1997-06-30 | $0.01B | $0.01B | 42.86% |
| 1997-03-31 | $0.01B | $0.01B | 57.14% |
| 1996-12-31 | $0.01B | $0.01B | 64.29% |
| 1996-09-30 | $0.01B | $0.01B | 84.62% |
| 1996-06-30 | $0.01B | $0.01B | 92.31% |
| 1996-03-31 | $0.01B | $0.01B | 81.82% |
| 1995-12-31 | $0.01B | $0.01B | 80.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.772B | $1.635B |
| Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $184.365B | 21.69 |
| Intuitive Surgical (ISRG) | United States | $160.029B | 61.73 |
| Edwards Lifesciences (EW) | United States | $44.895B | 30.42 |
| IDEXX Laboratories (IDXX) | United States | $44.716B | 43.08 |
| Alcon (ALC) | Switzerland | $38.585B | 25.49 |
| Waters (WAT) | United States | $31.413B | 24.37 |
| IQVIA Holdings (IQV) | United States | $28.398B | 15.40 |
| Mettler-Toledo (MTD) | United States | $26.829B | 30.97 |
| DexCom (DXCM) | United States | $24.639B | 30.63 |
| STERIS (STE) | Ireland | $21.830B | 22.08 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| Coloplast (CLPBY) | Denmark | $15.055B | 23.03 |
| SONOVA HOLDING (SONVY) | Switzerland | $13.774B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.199B | 9.72 |
| Penumbra (PEN) | United States | $12.941B | 85.88 |
| Globus Medical (GMED) | United States | $12.230B | 22.60 |
| Masimo (MASI) | United States | $9.578B | 30.69 |
| Glaukos (GKOS) | United States | $6.760B | 0.00 |
| SARTORIUS (SSSGY) | Germany | $6.754B | 39.22 |
| Sysmex ADR (SSMXY) | Japan | $5.470B | 18.10 |
| Teleflex (TFX) | United States | $5.233B | 9.67 |
| TransMedics (TMDX) | United States | $3.910B | 40.00 |
| LivaNova (LIVN) | United Kingdom | $3.433B | 18.41 |
| Integer Holdings (ITGR) | United States | $2.900B | 13.28 |
| Veracyte (VCYT) | United States | $2.470B | 24.48 |
| Elekta AB (EKTAY) | Sweden | $2.226B | 20.13 |
| Artivion (AORT) | United States | $1.825B | 59.73 |
| AxoGen (AXGN) | United States | $1.659B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.650B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.642B | 18.12 |
| UFP Technologies (UFPT) | United States | $1.552B | 20.54 |
| Tandem Diabetes Care (TNDM) | United States | $1.314B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.308B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.269B | 0.00 |
| IRadimed (IRMD) | United States | $1.194B | 53.37 |
| OPKO Health (OPK) | United States | $0.881B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.659B | 15.09 |
| Alpha Tau Medical (DRTS) | Israel | $0.618B | 0.00 |
| SiBone (SIBN) | United States | $0.567B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.552B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.533B | 28.23 |
| Mesa Laboratories (MLAB) | United States | $0.530B | 13.79 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.497B | 0.00 |
| NeuroPace (NPCE) | United States | $0.480B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.405B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.405B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.404B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.393B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.346B | 143.43 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.296B | 0.00 |
| RxSight (RXST) | United States | $0.282B | 0.00 |
| 908 Devices (MASS) | United States | $0.267B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.257B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.203B | 0.00 |
| CVRx (CVRX) | United States | $0.188B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.186B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.174B | 0.00 |
| Inogen (INGN) | United States | $0.172B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.148B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.124B | 0.00 |
| Hyperfine (HYPR) | United States | $0.119B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.117B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.111B | 0.00 |
| Solana (HSDT) | United States | $0.104B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.096B | 0.00 |
| Neuronetics (STIM) | United States | $0.094B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.083B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.074B | 0.00 |
| LENSAR (LNSR) | United States | $0.069B | 0.00 |
| Positron (POSC) | United States | $0.062B | 0.00 |
| InspireMD (NSPR) | United States | $0.060B | 0.00 |
| Spectral AI (MDAI) | United States | $0.055B | 0.00 |
| DarioHealth (DRIO) | United States | $0.053B | 0.00 |
| Envoy Medical (COCH) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.047B | 0.00 | |
| Accuray (ARAY) | United States | $0.046B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.028B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| NexGel (NXGL) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |